Esprit BTK Post-Approval Study

Clinical trial NCT06656364 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06656364
Sponsor: Abbott Medical Devices
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Limb-Threatening Ischemia

Start date: 2024-10-21
Primary completion: 2027-04-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.